HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
(In millions)
Three months ended | |||||||
July 31, 2021 | July 31, 2020 | ||||||
Cash flows from operating activities: | |||||||
Net earnings | $ | 1,108 | $ | 734 | |||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||
Depreciation and amortization | 196 | 197 | |||||
Stock-based compensation expense | 69 | 49 | |||||
Restructuring and other charges | 56 | 59 | |||||
Deferred taxes on earnings | (143 | ) | 32 | ||||
Other, net | 153 | 128 | |||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Accounts receivable | 168 | (157 | ) | ||||
Inventory | (670 | ) | 398 | ||||
Accounts payable | 625 | 85 | |||||
Net investment in leases | (40 | ) | (27 | ) | |||
Taxes on earnings | 118 | (89 | ) | ||||
Restructuring and other | (51 | ) | (75 | ) | |||
Other assets and liabilities | (496 | ) | 333 | ||||
Net cash provided by operating activities | 1,093 | 1,667 | |||||
Cash flows from investing activities: | |||||||
Investment in property, plant and equipment | (158 | ) | (117 | ) | |||
Purchases of available-for-sale securities and other investments | (11 | ) | (230 | ) | |||
Maturities and sales of available-for-sale securities and other investments | 9 | | |||||
Collateral posted for derivative instruments | 275 | (240 | ) | ||||
Payment made in connection with business acquisition, net of cash acquired | (412 | ) | | ||||
Net cash used in investing activities | (297 | ) | (587 | ) | |||
Cash flows from financing activities: | |||||||
Payment of short-term borrowings with original maturities less than 90 days, net | | (613 | ) | ||||
Proceed from short-term borrowings with original maturities greater than 90 days | 10 | 8 | |||||
Proceeds from debt, net of issuance costs | 2,004 | 2,993 | |||||
Payment of debt | (1,066 | ) | (1,662 | ) | |||
Stock-based award activities and others | 8 | 23 | |||||
Repurchase of common stock | (1,507 | ) | (953 | ) | |||
Cash dividends paid | (230 | ) | (251 | ) | |||
Net cash used in financing activities | (781 | ) | (455 | ) | |||
Increase in cash and cash equivalent | 15 | 625 | |||||
Cash and cash equivalents at beginning of period | 3,424 | 4,054 | |||||
Cash and cash equivalents at end of period | $ | 3,439 | $ | 4,679 |